Mergers & Acquisitions
Jul. 8, 2003
Pharmaceutical Firms Will Join Forces
In another massive biotechnology deal, Biogen Inc. and Idec Pharmaceuticals Corp. have agreed to merge in a multibillion-dollar stock swap.
The deal was valued at $6.4 billion when it was announced in June, making it the largest biotech deal since the $17.7 billion merger of Amgen Inc. and Immunex Corp. that closed ...